Table 2 Effects of Gas6 in various cancers
From: Molecular insights of Gas6/TAM in cancer development and therapy
System | Tumour type | Effect of Gas6 on tumour development | Underlying mechanism | Reference no. |
---|---|---|---|---|
Locomotor system | Osteosarcoma | Promotion | Akt activation | |
Circulatory system | Acute myeloid leukaemia | Promotion | ERK1/2, P38, MSK1 and CREB phosphorylation ATF-1, Akt and STAT6 activation | |
Acute lymphoblastic leukaemia | Promotion | Binding of Gas6 to Mer | ||
Nervous system | Schwannoma | Promotion | Src, FAK and NF-κB recruitment | |
Glioma | Promotion | Binding of Gas6 to Axl | ||
Endocrine system | Thyroid carcinoma | Promotion | Gas6-Tyro3/Axl autocrine circuit | |
Respiratory system | Lung cancer | Promotion | Binding of Gas6 to Axl | |
Digestive system | Oral squamous cell carcinoma | Promotion | Binding of Gas6 to Axl | |
Gastric cancer | Promotion | Binding of Gas6 to Axl | ||
Pancreatic ductal adenocarcinoma | Promotion | Akt activation | ||
Intestinal tumour | Inhibition | |||
Hepatocellular carcinoma | Promotion | Slug expression | ||
Urinary system | Prostate cancer | Promotion | Akt and MAPK phosphorylation | |
Renal cell carcinoma | Promotion | Binding of Gas6 to Axl | ||
Reproductive system | Uterine leiomyoma | Promotion | Binding of Gas6 to Axl | |
Ovarian carcinoma | Promotion | Binding of Gas6 to TAM | ||
Other cancers | Breast cancer | Promotion | Expression of PRB and Gas6 | |
Melanoma | Promotion | MAPK/ERK, PI3K/Akt, JAK/STAT activation |